Hong Fang Song serves as Executive at CG Oncology, Inc., where they oversee executive responsibilities. Since joining the company, Hong Fang Song has executed 10 insider transactions totaling $30.8M, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 3, 2025 involved selling 100 shares valued at $2.9K.
Hong Fang Song currently holds 2,903,931 shares of CG Oncology, Inc. (CGON), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Hong Fang Song has been a net seller of CGON stock. They have purchased $5.0M and sold $25.8M worth of shares.
Hong Fang Song's most recent insider trade was on Sep 3, 2025, when they sold 100 shares at $28.99 per share.
Get notified when new Form 4 filings are submitted
| $28.96 |
| Discretionary |
| Sep 3, 2025 | CGON | $850.2K | Sale | 30,105 | $28.24 | Discretionary |
| Sep 3, 2025 | CGON | $1.9M | Sale | 69,695 | $27.60 | Discretionary |
| Aug 29, 2024 | CGON | $8.0M | Sale | 226,245 | $35.36 | Discretionary |
| Aug 29, 2024 | CGON | $15.0M | Sale | 424,210 | $35.36 | Discretionary |
| Jan 29, 2024 | CGON | $5.0M | Purchase | 263,157 | $19.00 | Discretionary |
| Jan 29, 2024 | CGON | $0 | Conversion | 1,011,192 | $N/A | Discretionary |
| Jan 29, 2024 | CGON | $0 | Conversion | 3,930,176 | $N/A | Discretionary |
| Jan 29, 2024 | CGON | $0 | Conversion | 350,771 | $N/A | Discretionary |